TY - JOUR
T1 - A bioinformatics pipeline for estimating mitochondrial DNA copy number and heteroplasmy levels from whole genome sequencing data
AU - TOPMed mtDNA Working Group
AU - Battle, Stephanie L.
AU - Puiu, Daniela
AU - Verlouw, Joost
AU - Broer, Linda
AU - Boerwinkle, Eric
AU - Taylor, Kent D.
AU - Rotter, Jerome I.
AU - Rich, Stephan S.
AU - Grove, Megan L.
AU - Pankratz, Nathan
AU - Fetterman, Jessica L.
AU - Liu, Chunyu
AU - Arking, Dan E.
N1 - © The Author(s) 2022. Published by Oxford University Press on behalf of NAR Genomics and Bioinformatics.
PY - 2022/6/1
Y1 - 2022/6/1
N2 - Mitochondrial diseases are a heterogeneous group of disorders that can be caused by mutations in the nuclear or mitochondrial genome. Mitochondrial DNA (mtDNA) variants may exist in a state of heteroplasmy, where a percentage of DNA molecules harbor a variant, or homoplasmy, where all DNA molecules have the same variant. The relative quantity of mtDNA in a cell, or copy number (mtDNA-CN), is associated with mitochondrial function, human disease, and mortality. To facilitate accurate identification of heteroplasmy and quantify mtDNA-CN, we built a bioinformatics pipeline that takes whole genome sequencing data and outputs mitochondrial variants, and mtDNA-CN. We incorporate variant annotations to facilitate determination of variant significance. Our pipeline yields uniform coverage by remapping to a circularized chrM and by recovering reads falsely mapped to nuclear-encoded mitochondrial sequences. Notably, we construct a consensus chrM sequence for each sample and recall heteroplasmy against the sample's unique mitochondrial genome. We observe an approximately 3-fold increased association with age for heteroplasmic variants in non-homopolymer regions and, are better able to capture genetic variation in the D-loop of chrM compared to existing software. Our bioinformatics pipeline more accurately captures features of mitochondrial genetics than existing pipelines that are important in understanding how mitochondrial dysfunction contributes to disease.
AB - Mitochondrial diseases are a heterogeneous group of disorders that can be caused by mutations in the nuclear or mitochondrial genome. Mitochondrial DNA (mtDNA) variants may exist in a state of heteroplasmy, where a percentage of DNA molecules harbor a variant, or homoplasmy, where all DNA molecules have the same variant. The relative quantity of mtDNA in a cell, or copy number (mtDNA-CN), is associated with mitochondrial function, human disease, and mortality. To facilitate accurate identification of heteroplasmy and quantify mtDNA-CN, we built a bioinformatics pipeline that takes whole genome sequencing data and outputs mitochondrial variants, and mtDNA-CN. We incorporate variant annotations to facilitate determination of variant significance. Our pipeline yields uniform coverage by remapping to a circularized chrM and by recovering reads falsely mapped to nuclear-encoded mitochondrial sequences. Notably, we construct a consensus chrM sequence for each sample and recall heteroplasmy against the sample's unique mitochondrial genome. We observe an approximately 3-fold increased association with age for heteroplasmic variants in non-homopolymer regions and, are better able to capture genetic variation in the D-loop of chrM compared to existing software. Our bioinformatics pipeline more accurately captures features of mitochondrial genetics than existing pipelines that are important in understanding how mitochondrial dysfunction contributes to disease.
UR - http://www.scopus.com/inward/record.url?scp=85132984378&partnerID=8YFLogxK
U2 - 10.1093/nargab/lqac034
DO - 10.1093/nargab/lqac034
M3 - Article
C2 - 35591888
AN - SCOPUS:85132984378
SN - 2631-9268
VL - 4
SP - lqac034
JO - NAR Genomics and Bioinformatics
JF - NAR Genomics and Bioinformatics
IS - 2
M1 - lqac034
ER -